Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Liver Neoplasms × Nivolumab × Clear all

Phase

Phase 2 7 Phase 1 4 Phase 3 2 Phase 1/2 2 Phase EARLY_PHASE1 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Renal Cell 4 Melanoma 3 Kidney Neoplasms 3 Lung Neoplasms 2 Skin Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Liver Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Radiofrequency Ablation 3 atezolizumab 2 Sorafenib 2 Dexmedetomidine 2 Bevacizumab 2 voxilaprevir 1 velpatasvir 1 huachansu 1 gadolinium ethoxybenzyl DTPA 1 entecavir 1 Tobacco Use Cessation Devices 1 Telbivudine 1 Technetium Tc 99m Aggregated Albumin 1 Sofosbuvir 1 Sevoflurane 1 Ribavirin 1 Radionuclide Generators 1 Psychiatric Rehabilitation 1 Propofol 1 Pregabalin 1 Polymerase Chain Reaction 1 Oxaliplatin 1 Nivolumab 1 Neuroleptanalgesia 1 Lamivudine 1 Immunotherapy 1 Gene Expression Profiling 1 Galactose 1 Fluorouracil 1 Early Intervention, Educational 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04707547 2021-01-13

RFA

Taipei Medical University WanFang Hospital

Phase 4 Completed

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡